Savara Inc - SVRA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | TCG Crossover GP I, LLC | 6.1% | 12,362,205 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TCG Crossover Fund I, L.P. | 6.1% | 12,362,205 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Chen Yu | 6.1% | 12,362,205 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 9.9% | 20,881,288 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 9.9% | 20,881,288 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 9.9% | 20,881,288 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 9.9% | 20,881,288 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 9.9% | 20,881,288 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Nimish Shah | 9.9% | 20,881,288 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 9.9% | 20,881,288 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Frazier Life Sciences Public Fund, L.P. | 4.1% | 8,343,048 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLSP, L.P. | 4.1% | 8,343,048 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLSP, L.L.C. | 4.1% | 8,343,048 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Frazier Life Sciences X, L.P. | 0.1% | 279,365 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLS X, L.P. | 0.1% | 279,365 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLS X, L.L.C. | 0.1% | 279,365 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Frazier Life Sciences XI, L.P. | 0.6% | 1,239,888 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLS XI, L.P. | 0.6% | 1,239,888 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLS XI, L.L.C. | 0.6% | 1,239,888 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | James N. Topper | 0.1% | 279,365 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Patrick J. Heron | 0.1% | 279,365 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 3.61% | 7,344,783 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 3.61% | 7,344,783 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Daniel Mack | 3.61% | 7,344,783 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Farallon Capital Partners, L.P. | 1.2% | 2,488,500 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners, L.P. | 1.9% | 3,843,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners II, L.P. | 0.4% | 804,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners III, L.P. | 0.2% | 492,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Four Crossings Institutional Partners V, L.P. | 0.3% | 543,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Farallon Capital Offshore Investors II, L.P. | 2.7% | 5,659,500 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Farallon Capital (AM) Investors, L.P. | 0.1% | 204,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Farallon Capital F5 Master I, L.P. | 0.5% | 966,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Farallon Partners, L.L.C. | 6.5% | 14,034,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Farallon Institutional (GP) V, L.L.C. | 0.3% | 543,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Farallon F5 (GP), L.L.C. | 0.5% | 966,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Dapice Joshua J. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Dreyfuss, Philip D. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Dunn Hannah E. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Fried, Richard B | 0.0% | 0 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Gehani, Varun N. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Giauque, Nicolas | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Husen, Avner A. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Kim, David T. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Linn, Michael G. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Luo Patrick (Cheng) | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Patel, Rajiv A. | 0.0% | 0 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Roberts, Jr., Thomas G. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Saito Edric C. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Seybold, William | 0.0% | 0 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Short Daniel S. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Spokes, Andrew J. M. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Warren, John R. | 6.9% | 15,000,000 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Wehrly, Mark C. | 6.9% | 15,000,000 | View |
| Nov 14, 2025 | SCHEDULE 13G | Nantahala Capital Management, LLC | 5.08% | 8,775,375 | View |
| Nov 14, 2025 | SCHEDULE 13G | Wilmot B. Harkey | 5.08% | 8,775,375 | View |
| Nov 14, 2025 | SCHEDULE 13G | Daniel Mack | 5.08% | 8,775,375 | View |
| Nov 14, 2025 | SCHEDULE 13D/A | — | 1.0% | — | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 7.3% | 12,681,043 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 7.3% | 12,681,043 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 7.3% | 12,681,043 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Management III, LLC | 7.3% | 12,681,043 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Management EG, LLC | 7.3% | 12,681,043 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Nimish Shah | 7.3% | 12,681,043 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Bong Y. Koh | 7.3% | 12,681,043 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Vestal Point Capital, LP | 2.3% | 4,015,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ryan Wilder | 2.3% | 4,015,000 | View |
| Nov 05, 2025 | SCHEDULE 13G | Deerfield Mgmt, L.P. | 6.74% | 13,569,000 | View |
| Nov 05, 2025 | SCHEDULE 13G | Deerfield Management Company, L.P. | 6.74% | 13,569,000 | View |
| Nov 05, 2025 | SCHEDULE 13G | Deerfield Partners, L.P. | 6.74% | 13,569,000 | View |
| Nov 05, 2025 | SCHEDULE 13G | James E. Flynn | 6.74% | 13,569,000 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.